These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11750347)

  • 21. Estimated area-under-the-curve monitoring of Neoral in a stable pediatric renal transplant population: one-year experience.
    Lemire J; Capparelli EV; MacDonald D; Benador N; Reznik VM; Mendoza SA; Griswold WR
    Transplant Proc; 1998 Aug; 30(5):1983-4. PubMed ID: 9723361
    [No Abstract]   [Full Text] [Related]  

  • 22. Is the lower cyclosporine concentration at 2 hours after dosing safe in kidney transplant recipients?
    Einollahi B; Rostami Z; Kalantar E; Lessan-Pezeshki M; Pourfarziani V; Nemati E
    Transplant Proc; 2011 Mar; 43(2):488-90. PubMed ID: 21440741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-center study utilizing C(2) level as monitoring tool in de novo renal transplant recipients treated with Neoral.
    Keshavamurthy M; Al Ahmadi I; Mohammed Raza S; Baynton R; Al Meshari K; Al Shaibani K
    Transplant Proc; 2001; 33(7-8):3112-4. PubMed ID: 11750338
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of postdose cyclosporine monitoring in living renal transplant recipients.
    Thomas R; Minz M; Singh B; Heer M; Kashyap R
    Transplant Proc; 2004 Sep; 36(7):2104. PubMed ID: 15518761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A two-year study of the new cyclosporine formulation Consupren in de novo renal transplant patients.
    Stephan AG; Barbari A; Masri M; Kamel G; Barakat Khoury W; Karam A; Mokhbat J; Kilany H
    Transplant Proc; 1998 Nov; 30(7):3563-4. PubMed ID: 9838560
    [No Abstract]   [Full Text] [Related]  

  • 26. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
    Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation.
    Bunnag S; Vareesangthip K; Ong-ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S228-34. PubMed ID: 17044476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion of C-0 to C-2 monitoring of cyclosporine in stable kidney transplant patients.
    Jirasiritham S; Mavichak V; Danviriyasup K; Jirasiritham S
    Transplant Proc; 2003 Feb; 35(1):236-7. PubMed ID: 12591379
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclosporine neoral monitoring and its correlation with the "area under the curve".
    Sabbatiello R; Sgrosso JL; Schiavelli R; Castro C; Ahualli L; Pattin M; Vazquez MC
    Transplant Proc; 1996 Dec; 28(6):3378. PubMed ID: 8962317
    [No Abstract]   [Full Text] [Related]  

  • 30. Convenience of level of cyclosporine-Neoral at time 3 to determine the area under curve in renal transplant.
    Rial MC; Frias S; Argento J; Tessler J; Casadei D
    Transplant Proc; 1997; 29(1-2):292-3. PubMed ID: 9123001
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic drug monitoring of cyclosporine and area under the curve prediction using a single time point strategy: appraisal using peak concentration data.
    Srinivas NR
    Biopharm Drug Dispos; 2015 Dec; 36(9):575-86. PubMed ID: 26224332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preprandial C2 monitoring of cyclosporine treatment in children with nephrotic syndrome.
    Fujinaga S; Kaneko K; Takada M; Ohtomo Y; Akashi S; Yamashiro Y
    Pediatr Nephrol; 2005 Sep; 20(9):1359-60. PubMed ID: 15918005
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclosporin C2hour monitoring after renal transplantation.
    Einecke G; Mai I; Fritsche L; Slowinski T; Waiser J; Glander P; Böhler T; Neumayer HH; Budde K
    Int J Clin Pharmacol Ther; 2003 Oct; 41(10):477-81. PubMed ID: 14703954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of the therapeutic drug monitoring of cyclosporine.
    Citterio F
    Transplant Proc; 2004 Mar; 36(2 Suppl):420S-425S. PubMed ID: 15041378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variability of Sandimmune pharmacokinetics in renal transplant patients.
    Wingerchuk C; Heim-Duthoy KL; Macres MG; Kasiske BL
    Transplant Proc; 1998 Aug; 30(5):1656-7. PubMed ID: 9723230
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclosporine absorption profiling and therapeutic drug monitoring using C(2) blood levels in stable renal allograft recipients.
    Einecke G; Mai I; Diekmann F; Fritsche L; Neumayer HH; Budde K
    Transplant Proc; 2002 Aug; 34(5):1738-9. PubMed ID: 12176557
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetics of abbreviated AUC of cyclosporine in renal allograft recipients in a Pakistani population.
    Zafar MN; Abbas K; Naqvi A; Rizvi A
    Transplant Proc; 1999 Dec; 31(8):3304. PubMed ID: 10616486
    [No Abstract]   [Full Text] [Related]  

  • 38. The area under the concentration-time curve versus trough and peak blood level monitoring in renal transplant recipients on cyclosporine.
    Halim MA; Nampoory MR; Johny KV; Donia F; Hamid MH; Said T; Nair MP; Mansour M; Al-Muzairai I; Samhan M; Al-Mousawi M
    Transplant Proc; 2005 Sep; 37(7):3019-21. PubMed ID: 16213291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-hour postdose cyclosporine level monitoring: less rejection and more nephrotoxicity?
    Domínguez J; Tomic A; Norambuena R
    Transplant Proc; 2001; 33(7-8):3120-1. PubMed ID: 11750341
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclosporine monitoring in stable, long-term, pediatric kidney transplant recipients: the value of C2 determination.
    Ferraresso M; Ghio L; Tirelli S; Pedotti P; Taioli E; Edefonti A; Berardinelli L
    Transplant Proc; 2004 Apr; 36(3):685-6. PubMed ID: 15110630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.